230 related articles for article (PubMed ID: 36834718)
1. New Insights into the Biological Response Triggered by Dextran-Coated Maghemite Nanoparticles in Pancreatic Cancer Cells and Their Potential for Theranostic Applications.
Balas M; Predoi D; Burtea C; Dinischiotu A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834718
[TBL] [Abstract][Full Text] [Related]
2. Response of the Endogenous Antioxidant Defense System Induced in RAW 264.7 Macrophages upon Exposure to Dextran-Coated Iron Oxide Nanoparticles.
Balas M; Iconaru SL; Dinischiotu A; Buton N; Predoi D
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839874
[TBL] [Abstract][Full Text] [Related]
3. Low toxic maghemite nanoparticles for theranostic applications.
Kuchma EA; Zolotukhin PV; Belanova AA; Soldatov MA; Lastovina TA; Kubrin SP; Nikolsky AV; Mirmikova LI; Soldatov AV
Int J Nanomedicine; 2017; 12():6365-6371. PubMed ID: 28919740
[TBL] [Abstract][Full Text] [Related]
4. Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer.
Azhdarzadeh M; Atyabi F; Saei AA; Varnamkhasti BS; Omidi Y; Fateh M; Ghavami M; Shanehsazzadeh S; Dinarvand R
Colloids Surf B Biointerfaces; 2016 Jul; 143():224-232. PubMed ID: 27015647
[TBL] [Abstract][Full Text] [Related]
5. Theranostic nanoparticles based on magnetic nanoparticles: design, preparation, characterization, and evaluation as novel anticancer drug carrier and MRI contrast agent.
Nosrati H; Salehiabar M; Kheiri Manjili H; Davaran S; Danafar H
Drug Dev Ind Pharm; 2018 Oct; 44(10):1668-1678. PubMed ID: 29848101
[TBL] [Abstract][Full Text] [Related]
6. Bio-redox potential of Hyphaene thebaica in bio-fabrication of ultrafine maghemite phase iron oxide nanoparticles (Fe
Mohamed HEA; Afridi S; Khalil AT; Ali M; Zohra T; Salman M; Ikram A; Shinwari ZK; Maaza M
Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110890. PubMed ID: 32409045
[TBL] [Abstract][Full Text] [Related]
7.
Mortezazadeh T; Gholibegloo E; Khoobi M; Alam NR; Haghgoo S; Mesbahi A
J Drug Target; 2020 Jun; 28(5):533-546. PubMed ID: 31842616
[No Abstract] [Full Text] [Related]
8. Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for pancreatic cancer.
Dobiasch S; Szanyi S; Kjaev A; Werner J; Strauss A; Weis C; Grenacher L; Kapilov-Buchman K; Israel LL; Lellouche JP; Locatelli E; Franchini MC; Vandooren J; Opdenakker G; Felix K
J Nanobiotechnology; 2016 Dec; 14(1):81. PubMed ID: 27993133
[TBL] [Abstract][Full Text] [Related]
9. Redox-responsive dextran based theranostic nanoparticles for near-infrared/magnetic resonance imaging and magnetically targeted photodynamic therapy.
Ding Z; Liu P; Hu D; Sheng Z; Yi H; Gao G; Wu Y; Zhang P; Ling S; Cai L
Biomater Sci; 2017 Mar; 5(4):762-771. PubMed ID: 28256661
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of modified magnetic nanoparticles as theranostic agents: in vitro safety assessment in healthy cells.
Prokopiou E D; Pissas M; Fibbi G; Margheri F; Kalska-Szostko B; Papanastasiou G; Jansen M; Wang J; Laurenzana A; Efthimiadou K E
Toxicol In Vitro; 2021 Apr; 72():105094. PubMed ID: 33460736
[TBL] [Abstract][Full Text] [Related]
11. High efficacy of tamoxifen-loaded L-lysine coated magnetic iron oxide nanoparticles in cell cycle arrest and anti-cancer activity for breast cancer therapy.
Rostami S; Tafvizi F; Kheiri Manjili HR
Bioimpacts; 2022; 12(4):301-313. PubMed ID: 35975200
[No Abstract] [Full Text] [Related]
12. Amphipathic silica nanoparticles induce cytotoxicity through oxidative stress mediated and p53 dependent apoptosis pathway in human liver cell line HL-7702 and rat liver cell line BRL-3A.
Zuo D; Duan Z; Jia Y; Chu T; He Q; Yuan J; Dai W; Li Z; Xing L; Wu Y
Colloids Surf B Biointerfaces; 2016 Sep; 145():232-240. PubMed ID: 27187187
[TBL] [Abstract][Full Text] [Related]
13. Investigation of Dextran-Coated Superparamagnetic Nanoparticles for Targeted Vinblastine Controlled Release, Delivery, Apoptosis Induction, and Gene Expression in Pancreatic Cancer Cells.
Albukhaty S; Al-Musawi S; Abdul Mahdi S; Sulaiman GM; Alwahibi MS; Dewir YH; Soliman DA; Rizwana H
Molecules; 2020 Oct; 25(20):. PubMed ID: 33076247
[TBL] [Abstract][Full Text] [Related]
14. Phenyl alanine & Tyrosine Amino acids Coated Magnetic Nanoparticles: Preparation and Toxicity study.
Nosrati H; Hamzehei H; Afroogh S; Ashabi SF; Attari E; Manjili HK
Drug Res (Stuttg); 2019 May; 69(5):277-283. PubMed ID: 30189461
[TBL] [Abstract][Full Text] [Related]
15. Iron oxide nanoparticles modulate heat shock proteins and organ specific markers expression in mice male accessory organs.
Sundarraj K; Raghunath A; Panneerselvam L; Perumal E
Toxicol Appl Pharmacol; 2017 Feb; 317():12-24. PubMed ID: 28077287
[TBL] [Abstract][Full Text] [Related]
16. One-pot preparation of hyaluronic acid-coated iron oxide nanoparticles for magnetic hyperthermia therapy and targeting CD44-overexpressing cancer cells.
Soleymani M; Velashjerdi M; Shaterabadi Z; Barati A
Carbohydr Polym; 2020 Jun; 237():116130. PubMed ID: 32241421
[TBL] [Abstract][Full Text] [Related]
17. A biocompatible theranostic nanoplatform based on magnetic gadolinium-chelated polycyclodextrin: in vitro and in vivo studies.
Mansouri H; Gholibegloo E; Mortezazadeh T; Yazdi MH; Ashouri F; Malekzadeh R; Najafi A; Foroumadi A; Khoobi M
Carbohydr Polym; 2021 Feb; 254():117262. PubMed ID: 33357850
[TBL] [Abstract][Full Text] [Related]
18. Oridonin-loaded and GPC1-targeted gold nanoparticles for multimodal imaging and therapy in pancreatic cancer.
Qiu W; Chen R; Chen X; Zhang H; Song L; Cui W; Zhang J; Ye D; Zhang Y; Wang Z
Int J Nanomedicine; 2018; 13():6809-6827. PubMed ID: 30425490
[TBL] [Abstract][Full Text] [Related]
19. Hierarchical self-assembly of magnetic nanoclusters for theranostics: Tunable size, enhanced magnetic resonance imagability, and controlled and targeted drug delivery.
Nguyen DH; Lee JS; Choi JH; Park KM; Lee Y; Park KD
Acta Biomater; 2016 Apr; 35():109-17. PubMed ID: 26884278
[TBL] [Abstract][Full Text] [Related]
20. Oxi-Redox Selective Breast Cancer Treatment: An In Vitro Study of Theranostic In-Based Oxide Nanoparticles for Controlled Generation or Prevention of Oxidative Stress.
Hsu NS; Tehei M; Hossain MS; Rosenfeld A; Shiddiky MJA; Sluyter R; Dou SX; Yamauchi Y; Konstantinov K
ACS Appl Mater Interfaces; 2021 Jan; 13(2):2204-2217. PubMed ID: 33399455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
